Natural anti-IgG antibodies to autologous and heterologous species IgG

L. Fuller, M. Carreno, V. Esquenazi, D. Roth, J. Miller

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

In the present report we have isolated by affinity chromatography a putative human Fab2 that binds to human Fab2. We have examined the binding specificity of the Fab2 anti-Fab2 to IgG, Fab2, Fab, and Fc fragments derived from various species IgG and have attempted to isolate species-specific antibody by affinity chromatography. The results obtained in this study using 125I-Fab2 anti-Fab2 demonstrate that the natural antihuman antibodies cannot be separated into IgG species-specific population. Moreover, subjecting affinity-isolated Fab2 anti-Fab2 to a Sepharose 4B-mouse IgG column failed to remove mouse IgG-specific binding activity. These data suggest that the human natural antibodies, ie, Fab2 anti-Fab2 recognize homology epitopes (domain) and not species-specific IgG epitopes. The observation that Fab2 anti-Fab2 reacts with the Fc fragment as well as Fab supports this hypothesis. Additionally, the binding specificity of the Fab2 that was bound (fractions 30-35) by the Sepharose 4B-mouse IgG column exhibited the same reactivity as the nonbound fractions 5,6. The observation that Fab2 that were bound by the Sepharose 4B-mouse IgG suggest that this population contained molecules with higher binding affinities than the Fab2 in fractions 5,6.

Original languageEnglish (US)
Pages (from-to)45-46
Number of pages2
JournalTransplantation proceedings
Volume20
Issue number1 SUPPL. 1
StatePublished - Jan 1 1988

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint Dive into the research topics of 'Natural anti-IgG antibodies to autologous and heterologous species IgG'. Together they form a unique fingerprint.

  • Cite this

    Fuller, L., Carreno, M., Esquenazi, V., Roth, D., & Miller, J. (1988). Natural anti-IgG antibodies to autologous and heterologous species IgG. Transplantation proceedings, 20(1 SUPPL. 1), 45-46.